论文部分内容阅读
为了确定急性心肌梗塞经溶栓治疗后施行冠脉成形术的时机和效果,近年来进行三项大规模随机试验:心肌梗塞溶栓治疗(TIMI Ⅱ),溶栓治疗和心肌梗塞(TAMI)以及欧洲协作研究组(ECSG)。三项试验中,病人年龄<70~75岁,胸痛至少20~30分钟,伴 ST 段抬高≥0.1mv,从发病到开始治疗的时间≤4~5小时;采用重组的组织型纤溶酶原激活剂(rt-PA100mg),另予肝素和阿司匹林。对于急性心
In order to determine the timing and effect of coronary angioplasty after thrombolysis in patients with acute myocardial infarction, three large randomized trials have been performed in recent years: TIMI II, thrombolytic therapy, and myocardial infarction (TAMI) European Collaborative Research Group (ECSG). Three trials, patients aged <70 to 75 years old, chest pain at least 20 to 30 minutes, with ST-segment elevation ≥ 0.1mv, from onset to treatment time ≤ 4 ~ 5 hours; recombinant tissue plasminogen The original activator (rt-PA100mg), the other to heparin and aspirin. For acute heart